कृपया अन्य खोज का प्रयास करें
Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia; NEX-20 for the treatment of multiple myeloma; and NEX-22 for the treatment of type 2 diabetes. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Goran A. Ando | 73 | 2020 | Independent Chairman of the Board |
Eva Nilsagard | 59 | 2021 | Independent Director |
Magnus Westgren | 73 | 2015 | Independent Director |
Axel Gaston Glasmacher | 63 | - | Member of Advisory Board - NEX-18 & NEX-20 |
Kirsten Gronbaek | - | - | Member of Advisory Board - NEX-18 |
Birgit Stattin Norinder | 75 | 2021 | Independent Director |
Xavier Leleu | - | - | Member of Advisory Board - NEX-20 |
Richard Davis | 50 | 2022 | Independent Director |
Uwe Platzbecker | - | - | Member of Advisory Board - NEX-18 |
Jose Miguel Torregrosa Diaz | - | - | Member of Advisory Board - NEX-18 |
Robert Peter Gale | - | - | Member of Advisory Board - NEX-18 |
Christopher Maisel | - | - | Member of Advisory Board - NEX-20 |
Karthik Ramasamy | - | - | Member of Advisory Board - NEX-20 |
Marie von Lilienfeld-Toa | - | - | Member of Advisory Board - NEX-20 |
Magnus Tobiasson | - | - | Member of Advisory Board - NEX-18 |
Jakob Dynnes Hansen | 69 | 2023 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है